Craneware (LON:CRW) Share Price Passes Below 200 Day Moving Average - Here's Why

Key Points

• Craneware's share price fell below its 200-day moving average of GBX 1,808.39, trading as low as GBX 1,508 and last at GBX 1,564 on volume of 303,490 shares.
• Analysts maintain a consensus Buy rating with an average target of GBX 2,297.75, implying substantial upside from current levels.
• The company has a market cap of £546.56m and a PE of 24.77, but a high debt-to-equity ratio (7.93) and a current ratio below 1 (0.76) highlight potential leverage and liquidity risks.

Craneware plc (LON:CRW - Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,808.39 and traded as low as GBX 1,508. Craneware shares last traded at GBX 1,564, with a volume of 303,490 shares changing hands.

Wall Street Analysts Forecast Growth

CRW has been the subject of a number of research reports. Shore Capital Group reiterated a "buy" rating and set a GBX 2,850 target price on shares of Craneware in a research report on Tuesday, January 20th. UBS Group reiterated a "buy" rating and set a GBX 570 target price on shares of Craneware in a research report on Wednesday, March 25th. Finally, Berenberg Bank reiterated a "buy" rating and set a GBX 2,900 target price on shares of Craneware in a research report on Tuesday, January 20th. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of GBX 2,297.75.

Craneware Stock Down 0.4%

The company has a debt-to-equity ratio of 7.93, a quick ratio of 1.00 and a current ratio of 0.76. The company has a fifty day moving average of GBX 1,423.68 and a two-hundred day moving average of GBX 1,808.39. The company has a market cap of £546.56 million, a PE ratio of 24.77 and a beta of 0.28.

Craneware Company Profile

For over 25 years, The Craneware Group AIM: CRW.L has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.